Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Andersson

Showing results (851-860 of 945) with videos related to

Pageof 95
Sort By:
Journal of Pharmaceutical Sciences|October 30, 2020
Primary Human Hepatocyte Spheroid Model as a 3D In Vitro Platform for Metabolism StudiesKajsa P Kanebratt, Annika Janefeldt, Liisa Vilén, et al.
Cancer|August 15, 1988
Mitoxantrone and high-dose cytosine arabinoside in refractory acute myelogenous leukemiaR S Walters, H M Kantarjian, M J Keating, et al.
Genome Research|April 1, 1997
Large-scale concatenation cDNA sequencingW Yu, B Andersson, K C Worley, et al.
Hematologic Pathology|January 1, 1988
Heterogeneity in acute undifferentiated leukemiaA LeMaistre, C C Childs, C Hirsch-Ginsberg, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 29, 2000
1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MSJ Suhy, W D Rooney, D E Goodkin, et al.
Acta Anaesthesiologica Scandinavica|June 11, 2011
Scandinavian glutamine trial: a pragmatic multi-centre randomised clinical trial of intensive care unit patientsJan Wernerman, T Kirketeig, B Andersson, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|January 15, 2008
Prediction of drug-induced liver injury in humans by using in vitro methods: the case of ximelagatranKerstin Kenne, Inger Skanberg, Bjorn Glinghammar, et al.
Biotechnology and Bioengineering|June 13, 2012
Analysis of drug metabolism activities in a miniaturized liver cell bioreactor for use in pharmacological studiesStefan A Hoffmann, Ursula Müller-Vieira, Klaus Biemel, et al.
Bone Marrow Transplantation|April 21, 2001
Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survivalK van Besien, A Rodriguez, S Tomany, et al.
The Journal of Clinical Endocrinology and Metabolism|October 9, 2004
Cartilage oligomeric matrix protein increases in serum after the start of growth hormone treatment in prepubertal childrenR Bjarnason, B Andersson, H S Kim, et al.
Pageof 95

Showing results (851-860 of 945) with videos related to

Sort By:
Pageof 95
Journal of Pharmaceutical Sciences|October 30, 2020
Primary Human Hepatocyte Spheroid Model as a 3D In Vitro Platform for Metabolism StudiesKajsa P Kanebratt, Annika Janefeldt, Liisa Vilén, et al.
Cancer|August 15, 1988
Mitoxantrone and high-dose cytosine arabinoside in refractory acute myelogenous leukemiaR S Walters, H M Kantarjian, M J Keating, et al.
Genome Research|April 1, 1997
Large-scale concatenation cDNA sequencingW Yu, B Andersson, K C Worley, et al.
Hematologic Pathology|January 1, 1988
Heterogeneity in acute undifferentiated leukemiaA LeMaistre, C C Childs, C Hirsch-Ginsberg, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 29, 2000
1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MSJ Suhy, W D Rooney, D E Goodkin, et al.
Acta Anaesthesiologica Scandinavica|June 11, 2011
Scandinavian glutamine trial: a pragmatic multi-centre randomised clinical trial of intensive care unit patientsJan Wernerman, T Kirketeig, B Andersson, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|January 15, 2008
Prediction of drug-induced liver injury in humans by using in vitro methods: the case of ximelagatranKerstin Kenne, Inger Skanberg, Bjorn Glinghammar, et al.
Biotechnology and Bioengineering|June 13, 2012
Analysis of drug metabolism activities in a miniaturized liver cell bioreactor for use in pharmacological studiesStefan A Hoffmann, Ursula Müller-Vieira, Klaus Biemel, et al.
Bone Marrow Transplantation|April 21, 2001
Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survivalK van Besien, A Rodriguez, S Tomany, et al.
The Journal of Clinical Endocrinology and Metabolism|October 9, 2004
Cartilage oligomeric matrix protein increases in serum after the start of growth hormone treatment in prepubertal childrenR Bjarnason, B Andersson, H S Kim, et al.
Pageof 95